PLGA, PLA, PCL polymers for Controlled Drug Delivery

Introduction: PLA stereochemistry — specifically the ratio and arrangement of L- and D-lactic acid units — determines crystallinity, degradation rate, […]

Procurement Strategies for PLGA, PLA, PCL, and IND-Enabling Studies Supply Sourcing biodegradable polymers for IND-enabling studies requires the selection of

Designing Controlled-Release Systems Through Aliphatic Polyester Erosion Selecting the most appropriate bioresorbable matrix for long-acting drug delivery systems or implantable

Introduction to PLGA CNS Drug Delivery Blood-Brain Barrier Systems PLGA CNS Drug Delivery Blood-Brain Barrier systems are advanced polymeric nanocarriers

Introduction to Encapsulating Hydrophilic vs Hydrophobic APIs in PLGA The development of clinically successful long-acting parenteral formulations depends on aligning

Introduction Burst release in PLGA formulations is one of the most clinically consequential — and analytically challenging — phenomena in

Introduction: Carmustine PLGA characterization sits at the intersection of polymer science, oncology pharmacology, and regulatory compliance — making it one

Introduction: Aripiprazole lauroxil (Aristada®) is a PLGA-based long-acting injectable antipsychotic that differs fundamentally from other LAI microsphere products. As discussed

Introduction: Goserelin PLGA implant characterization is one of the most technically demanding challenges in long-acting parenteral development — and also

Introduction to Interfacial Dynamics of Surfactants and Emulsifiers in PLGA Microsphere Fabrication The primary function of surfactants and emulsifiers in